"This study was initiated based on the compelling results from pre-clinical studies and an initial clinical trial," said lead researcher Michael H. Davidson, MD. "We are excited with the outcome of this larger study because while we did not see a reduction in the group as a whole, there is an indication that the rate of CIMT progression slowed in subgroups of patients characterized by more rapid CIMT progression."
In conclusion, the authors call for these preliminary findings to be investigated in future studies, because "consumption of pomegranate juice is very safe; thus demonstration of a benefit on atherosclerotic disease progression, even in a subset of the population, would have important public health implications."
The publication of this study is the most recent in series of studies evaluating the potential benefits of POM Wonderful 100% Pomegranate Juice on human health. In 1998 POM Wonderful initiated a world class medical research program to investigate the Wonderful variety pomegranate. To date, POM Wonderful has funded $32 million in research, which has involved a number of top scientists from leading universities around the world, including a Nobel Laureate. So far, 48 total studies have been published in peer-review journals. Primary research areas have included the prostate and cardiovascular, among others.
Source Cited:
M. Davidson et al., Effects of Consumption of Pomegranate Juice on Carotid Intima-Media Thickness in Men and Women at Moderate Risk for Coronary Heart Disease, American Journal of Cardiology (2009)
About POM Wonderful
POM Wonderful is the largest producer of California Wonderful pomegranates and the company exclusively grows and sells this variety. POM Wonderful's pomegranates grow in central California, in the su
'/>"/>
| SOURCE POM Wonderful Copyright©2009 PR Newswire. All rights reserved |